Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Abstract

The effects of exposure to unsaturated fatty acids on opiate receptors, prostaglandin E1 receptors, and adenylate cyclase activity of neuroblastoma x glioma hybrid cells.

R McGee Jr and J G Kenimer
Molecular Pharmacology September 1982, 22 (2) 360-368;
R McGee Jr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J G Kenimer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 22 no. 2 360-368
PubMed 
6292694

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111


Statistics from Altmetric.com

Article usage

Article usage: July 2001 to May 2021

AbstractFullPdf
Jul 2001100
Aug 2001200
May 2003100
Jun 2003100
Jul 2003400
Aug 2003300
Sep 2003200
Oct 2003300
Nov 2003400
Dec 2003400
Jan 2004500
Feb 2004100
Mar 2004400
Apr 2004300
May 2004500
Jun 2004700
Jul 2004800
Aug 2004300
Sep 2004300
Oct 2004500
Nov 2004300
Dec 2004200
Jan 2005500
Feb 2005100
Mar 2005200
Apr 2005200
May 2005100
Jun 2005101
Oct 2005200
Nov 2005002
Dec 2005101
Jan 2006002
Feb 2006006
Mar 2006301
Oct 2006001
May 2007100
Aug 2007100
Nov 2007100
Jan 2008100
Mar 2008100
Apr 2008100
Jun 2008100
Jul 2008100
Sep 2008300
Oct 2008100
Dec 2008200
Feb 2009100
Mar 2009002
Apr 2009001
May 2009100
Jul 2009100
Aug 2009002
Sep 2009400
Oct 2009400
Nov 2009200
Dec 2009100
Jan 2010001
Apr 2010004
Jul 2010003
Oct 2011001
Feb 2012002
May 2012001
Dec 2012005
Jun 2013002
Sep 2013001
Oct 2013101
May 2014001
Aug 2014001
Jul 2015100
Nov 2015002
Mar 2016001
Apr 2016001
Sep 2016100
Mar 2017001
Apr 2017001
May 2017003
May 2019002
Jun 2019002
May 2021001

PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 22, Issue 2
1 Sep 1982
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The effects of exposure to unsaturated fatty acids on opiate receptors, prostaglandin E1 receptors, and adenylate cyclase activity of neuroblastoma x glioma hybrid cells.
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract

The effects of exposure to unsaturated fatty acids on opiate receptors, prostaglandin E1 receptors, and adenylate cyclase activity of neuroblastoma x glioma hybrid cells.

R McGee and J G Kenimer
Molecular Pharmacology September 1, 1982, 22 (2) 360-368;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Abstract

The effects of exposure to unsaturated fatty acids on opiate receptors, prostaglandin E1 receptors, and adenylate cyclase activity of neuroblastoma x glioma hybrid cells.

R McGee and J G Kenimer
Molecular Pharmacology September 1, 1982, 22 (2) 360-368;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics